A resolution designating September 2020 as "National Ovarian Cancer Awareness Month".

III 116TH CONGRESS 2D SESSION S. RES. 727 Designating September 2020 as ‘‘National Ovarian Cancer Awareness Month’’. IN THE SENATE OF THE UNITED STATES SEPTEMBER 30 (legislative day, SEPTEMBER 29), 2020 Ms. STABENOW (for herself, Ms. MURKOWSKI, Mrs. FEINSTEIN, Mr. BROWN, Mr. BLUMENTHAL, Mr. PETERS, Mr. MENENDEZ, Mr. VAN HOLLEN, and Mrs. CAPITO) submitted the following resolution; which was referred to the Committee on the Judiciary RESOLUTION Designating September 2020 as ‘‘National Ovarian Cancer Awareness Month’’. Whereas ovarian cancer is the fifth leading cause of cancer deaths in women in the United States and accounts for more deaths than any other cancer of the female repro- ductive system; Whereas, in the United States, a woman’s lifetime risk of being diagnosed with ovarian cancer is about 1 in 78; Whereas the American Cancer Society estimates 21,750 new cases of ovarian cancer will be diagnosed in 2020 and 13,940 people will die from the disease nationwide; VerDate Sep 11 2014 07:17 Oct 01, 2020 Jkt 099200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6300 E:\BILLS\SR727.IS SR727 kjohnson on DSK79L0C42PROD with BILLS 2 •SRES 727 IS Whereas the 5-year survival rate for ovarian cancer is 46.5 percent, and survival rates vary greatly depending on the stage of diagnosis; Whereas the 5-year survival rate for ovarian cancer is over 90 percent for women diagnosed in early stages; Whereas, while the mammogram can detect breast cancer and the Pap smear can detect cervical cancer, there is no reli- able early detection test for ovarian cancer; Whereas, in June 2007, the first national consensus state- ment on ovarian cancer symptoms was developed to pro- vide consistency in describing symptoms and make it easier for women to learn and remember those symptoms; Whereas too many people remain unaware that the symptoms of ovarian cancer often include bloating, pelvic or abdom- inal pain, difficulty eating or feeling full quickly, urinary symptoms, and several other vague symptoms that are often easily confused with other diseases; Whereas improved awareness of the symptoms of ovarian cancer by the public and health care providers can lead to a quicker diagnosis; Whereas the lack of an early detection test for ovarian can- cer, combined with its vague symptoms, mean that ap- proximately 80 percent of cases of ovarian cancer are de- tected at an advanced stage; Whereas all women are at risk for ovarian cancer, but ap- proximately 20 percent of women who are diagnosed with ovarian cancer have a hereditary predisposition to ovar- ian cancer, which places them at even higher risk; Whereas scientists and physicians have uncovered changes in the BRCA genes that some women inherit from their VerDate Sep 11 2014 07:17 Oct 01, 2020 Jkt 099200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6300 E:\BILLS\SR727.IS SR727 kjohnson on DSK79L0C42PROD with BILLS 3 •SRES 727 IS parents, which may make those women 30 times more likely to develop ovarian cancer; Whereas the family history of a woman has been found to play an important role in accurately assessing a woman’s risk of developing ovarian cancer, and medical experts be- lieve that family history should be taken into consider- ation during the annual well-woman visit of any woman; Whereas women who know that they are at high risk of ovar- ian cancer may undertake prophylactic measures to help reduce the risk of developing this disease; Whereas guidelines issued by the National Comprehensive Cancer Network (NCCN) and the Society of Gynecologic Oncology (SGO) recommend that all individuals diag- nosed with ovarian cancer receive genetic counseling and genetic testing regardless of their family history; Whereas studies consistently show that compliance with such guidelines is alarmingly low, with recently published Na- tional Cancer Institute-funded research finding that in 2013 and 2014, only 1⁄3 of ovarian cancer survivors had undergone such testing; Whereas, according to a 2016 consensus report by the Na- tional Academy of Medicine, ‘‘there remain surprising gaps in the fundamental knowledge about and under- standing of ovarian cancer’’ across all aspects of the dis- ease; Whereas ongoing investments in ovarian cancer research and education and awareness efforts are critical to closing these gaps and improving survivorship for women with ovarian cancer; Whereas, each year during the month of September, the Ovarian Cancer Research Alliance (OCRA) and its com- VerDate Sep 11 2014 07:17 Oct 01, 2020 Jkt 099200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6300 E:\BILLS\SR727.IS SR727 kjohnson on DSK79L0C42PROD with BILLS 4 •SRES 727 IS munity partners hold a number of events to increase pub- lic awareness of ovarian cancer and its symptoms; and Whereas September 2020 should be designated as ‘‘National Ovarian Cancer Awareness Month’’ to increase public awareness of ovarian cancer: Now, therefore, be it Resolved, That the Senate— 1 (1) designates September 2020 as ‘‘National 2 Ovarian Cancer Awareness Month’’; and 3 (2) supports the goals and ideals of National 4 Ovarian Cancer Awareness Month. 5 Æ VerDate Sep 11 2014 07:17 Oct 01, 2020 Jkt 099200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6301 E:\BILLS\SR727.IS SR727 kjohnson on DSK79L0C42PROD with BILLS